» Articles » PMID: 27534815

Biochemical Characterization of APOBEC3H Variants: Implications for Their HIV-1 Restriction Activity and MC Modification

Overview
Journal J Mol Biol
Publisher Elsevier
Date 2016 Aug 19
PMID 27534815
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

APOBEC3H (A3H) is the most polymorphic member of the APOBEC3 family. Seven haplotypes (hap I-VII) and four mRNA splicing variants (SV) of A3H have been identified. The various haplotypes differ in anti-HIV activity, which is attributed to differences in protein stability, subcellular distribution, and/or RNA binding and virion packaging. Here, we report the first comparative biochemical studies of all the A3H variants using highly purified proteins. We show that all haplotypes were stably expressed and could be purified to homogeneity by Escherichia coli expression. Surprisingly, four out of the seven haplotypes showed high cytosine (C) deaminase activity, with hap V displaying extremely high activity that was comparable to the highly active A3A. Furthermore, all four haplotypes that were active in C deamination were also highly active on methylated C (mC), with hap II displaying almost equal deamination efficiency on both. The deamination activity of these A3H variants correlates well with their reported anti-HIV activity for the different haplotypes, suggesting that deaminase activity may be an important factor in determining their respective anti-HIV activities. Moreover, mC deamination of A3H displayed a strong preference for the sequence motif of T-mCpG-C/G, which may suggest a potential role in genomic mC modification at the characteristic "CpG" island motif.

Citing Articles

APOBEC3-Related Editing and Non-Editing Determinants of HIV-1 and HTLV-1 Restriction.

Leong S, Nasser H, Ikeda T Int J Mol Sci. 2025; 26(4).

PMID: 40004025 PMC: 11855278. DOI: 10.3390/ijms26041561.


Structural basis of HIV-1 Vif-mediated E3 ligase targeting of host APOBEC3H.

Ito F, Alvarez-Cabrera A, Kim K, Zhou Z, Chen X Nat Commun. 2023; 14(1):5241.

PMID: 37640699 PMC: 10462622. DOI: 10.1038/s41467-023-40955-x.


Competition for DNA binding between the genome protector replication protein A and the genome modifying APOBEC3 single-stranded DNA deaminases.

Wong L, Sami A, Chelico L Nucleic Acids Res. 2022; 50(21):12039-12057.

PMID: 36444883 PMC: 9757055. DOI: 10.1093/nar/gkac1121.


Human APOBEC3 Variations and Viral Infection.

Sadeghpour S, Khodaee S, Rahnama M, Rahimi H, Ebrahimi D Viruses. 2021; 13(7).

PMID: 34372572 PMC: 8310219. DOI: 10.3390/v13071366.


Insights into the Structures and Multimeric Status of APOBEC Proteins Involved in Viral Restriction and Other Cellular Functions.

Chen X Viruses. 2021; 13(3).

PMID: 33802945 PMC: 8002816. DOI: 10.3390/v13030497.


References
1.
Sakurai D, Iwatani Y, Ohtani H, Naruse T, Terunuma H, Sugiura W . APOBEC3H polymorphisms associated with the susceptibility to HIV-1 infection and AIDS progression in Japanese. Immunogenetics. 2015; 67(4):253-7. DOI: 10.1007/s00251-015-0829-2. View

2.
Conticello S . The AID/APOBEC family of nucleic acid mutators. Genome Biol. 2008; 9(6):229. PMC: 2481415. DOI: 10.1186/gb-2008-9-6-229. View

3.
Burns M, Lackey L, Carpenter M, Rathore A, Land A, Leonard B . APOBEC3B is an enzymatic source of mutation in breast cancer. Nature. 2013; 494(7437):366-70. PMC: 3907282. DOI: 10.1038/nature11881. View

4.
Caval V, Suspene R, Vartanian J, Wain-Hobson S . Orthologous mammalian APOBEC3A cytidine deaminases hypermutate nuclear DNA. Mol Biol Evol. 2013; 31(2):330-40. DOI: 10.1093/molbev/mst195. View

5.
Ooms M, Brayton B, Letko M, Maio S, Pilcher C, Hecht F . HIV-1 Vif adaptation to human APOBEC3H haplotypes. Cell Host Microbe. 2013; 14(4):411-21. DOI: 10.1016/j.chom.2013.09.006. View